$12.67
0.01000.08%
At Close: -
$12.67
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Calumet (NASDAQ:CLMT) Stock, Analyst Ratings, Price Targets, Forecasts
Calumet Inc has a consensus price target of $23.07 based on the ratings of 7 analysts. The high is $30 issued by Wolfe Research on November 23, 2021. The low is $17 issued by Goldman Sachs on March 21, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and Goldman Sachs on May 13, 2024, April 22, 2024, and March 21, 2024, respectively. With an average price target of $22.33 between HC Wainwright & Co., HC Wainwright & Co., and Goldman Sachs, there's an implied 76.27% upside for Calumet Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Goldman Sachs
UBS
Wells Fargo
TD Cowen
1calculated from analyst ratings
Analyst Ratings for Calumet
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/13/2024 | Buy Now | 97.32% | HC Wainwright & Co. | Amit Dayal | → $25 | Reiterates | Buy → Buy | Get Alert |
| 04/22/2024 | Buy Now | 97.32% | HC Wainwright & Co. | Amit Dayal | → $25 | Reiterates | Buy → Buy | Get Alert |
| 03/21/2024 | Buy Now | 34.18% | Goldman Sachs | Neil Mehta | $19 → $17 | Maintains | Buy | Get Alert |
| 12/14/2023 | Buy Now | 49.96% | Goldman Sachs | Neil Mehta | $17 → $19 | Maintains | Buy | Get Alert |
| 10/31/2023 | Buy Now | 34.18% | Goldman Sachs | Neil Mehta | $19 → $17 | Maintains | Buy | Get Alert |
| 08/07/2023 | Buy Now | 97.32% | HC Wainwright & Co. | Amit Dayal | → $25 | Reiterates | Buy → Buy | Get Alert |
| 06/13/2023 | Buy Now | 49.96% | Goldman Sachs | Neil Mehta | $20 → $19 | Maintains | Buy | Get Alert |
| 05/15/2023 | Buy Now | 53.91% | UBS | Manav Gupta | $18.5 → $19.5 | Maintains | Neutral | Get Alert |
| 05/08/2023 | Buy Now | 113.1% | Wells Fargo | Roger Read | $29 → $27 | Maintains | Overweight | Get Alert |
| 05/08/2023 | Buy Now | 81.53% | TD Cowen | Jason Gabelman | $21 → $23 | Maintains | Outperform | Get Alert |
| 01/25/2023 | Buy Now | 97.32% | HC Wainwright & Co. | Amit Dayal | $28 → $25 | Maintains | Buy | Get Alert |
| 12/14/2022 | Buy Now | 23.91% | UBS | Manav Gupta | → $15.7 | Initiates | → Neutral | Get Alert |
| 08/18/2022 | Buy Now | 81.53% | Goldman Sachs | Neil Mehta | $14 → $23 | Upgrade | Neutral → Buy | Get Alert |
| 06/28/2022 | Buy Now | 57.85% | Cowen & Co. | Jason Gabelman | $18 → $20 | Maintains | Outperform | Get Alert |
| 05/09/2022 | Buy Now | 57.85% | Cowen & Co. | Jason Gabelman | $18 → $20 | Maintains | Outperform | Get Alert |
| 04/21/2022 | Buy Now | 128.89% | Wells Fargo | Roger Read | $27 → $29 | Maintains | Overweight | Get Alert |
| 02/28/2022 | Buy Now | 120.99% | HC Wainwright & Co. | Amit Dayal | $19 → $28 | Maintains | Buy | Get Alert |
| 11/23/2021 | Buy Now | 136.78% | Wolfe Research | Sam Margolin | — | Upgrade | Peer Perform → Outperform | Get Alert |
| 11/23/2021 | Buy Now | 81.53% | Cowen & Co. | Jason Gabelman | — | Upgrade | Market Perform → Outperform | Get Alert |
| 10/15/2021 | Buy Now | -13.18% | Goldman Sachs | Neil Mehta | — | Maintains | Neutral | Get Alert |
| 10/08/2021 | Buy Now | -13.18% | Wells Fargo | Roger Read | — | Maintains | Overweight | Get Alert |
| 10/04/2021 | Buy Now | 49.96% | HC Wainwright & Co. | Amit Dayal | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Calumet (CLMT) stock?
The latest price target for Calumet (NASDAQ:CLMT) was reported by HC Wainwright & Co. on May 13, 2024. The analyst firm set a price target for $25.00 expecting CLMT to rise to within 12 months (a possible 97.32% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Calumet (CLMT)?
The latest analyst rating for Calumet (NASDAQ:CLMT) was provided by HC Wainwright & Co., and Calumet reiterated their buy rating.
When was the last upgrade for Calumet (CLMT)?
The last upgrade for Calumet Inc happened on August 18, 2022 when Goldman Sachs raised their price target to $23. Goldman Sachs previously had a neutral for Calumet Inc.
When was the last downgrade for Calumet (CLMT)?
There is no last downgrade for Calumet.
When is the next analyst rating going to be posted or updated for Calumet (CLMT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Calumet, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Calumet was filed on May 13, 2024 so you should expect the next rating to be made available sometime around May 13, 2025.
Is the Analyst Rating Calumet (CLMT) correct?
While ratings are subjective and will change, the latest Calumet (CLMT) rating was a reiterated with a price target of $25.00 to $25.00. The current price Calumet (CLMT) is trading at is $12.67, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.